StockNews.com Upgrades Quest Diagnostics (NYSE:DGX) to Buy
StockNews.com Upgrades Quest Diagnostics (NYSE:DGX) to Buy
StockNews.com upgraded shares of Quest Diagnostics (NYSE:DGX – Get Rating) from a hold rating to a buy rating in a research report report published on Tuesday morning.
在週二上午發佈的一份研究報告中，StockNews.com將Quest Diagnostics(NYSE：DGX-GET Rating)的股票評級從持有評級上調至買入評級。
Separately, Morgan Stanley reiterated an equal weight rating and issued a $142.00 price target on shares of Quest Diagnostics in a report on Monday, August 22nd. Six investment analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of Hold and a consensus target price of $148.50.
另外，摩根士丹利在8月22日週一的一份報告中重申了同等權重的評級，並對Quest Diagnostics的股票發佈了142.00美元的目標價。六名投資分析師對該股的評級為持有，三名分析師對該公司股票的評級為買入。根據MarketBeat的數據，該公司目前的共識評級為持有，共識目標價為148.50美元。
Quest Diagnostics Trading Down 1.5 %
Quest Diagnostics降價1.5%
Shares of DGX opened at $122.69 on Tuesday. The company has a current ratio of 1.54, a quick ratio of 1.42 and a debt-to-equity ratio of 0.62. The firm has a market capitalization of $14.31 billion, a P/E ratio of 10.41 and a beta of 1.01. The stock's fifty day simple moving average is $130.82 and its 200 day simple moving average is $134.90. Quest Diagnostics has a twelve month low of $120.40 and a twelve month high of $174.16.
週二，DGX的股價開盤報122.69美元。該公司的流動比率為1.54，速動比率為1.42，債務權益比率為0.62。該公司的市值為143.1億美元，市盈率為10.41，貝塔係數為1.01。該股的50日簡單移動均線切入位為130.82美元，200日簡單移動均線切入位為134.90美元。Quest Diagnostics的12個月低點為120.40美元，12個月高位為174.16美元。
Quest Diagnostics Announces Dividend
Quest Diagnostics宣佈分紅
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 19th. Shareholders of record on Tuesday, October 4th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Monday, October 3rd. This represents a $2.64 dividend on an annualized basis and a yield of 2.15%. Quest Diagnostics's dividend payout ratio is currently 21.96%.
該公司最近還宣佈了季度股息，將於10月19日星期三支付。10月4日(星期二)登記在冊的股東將獲得0.66美元的股息。本次股息除息日期為10月3日(星期一)。這意味着年化股息為2.64美元，收益率為2.15%。Quest Diagnostics的股息支付率目前為21.96%。
Insiders Place Their Bets
內部人士下注
In other news, Director Timothy M. Ring sold 2,000 shares of Quest Diagnostics stock in a transaction that occurred on Monday, August 1st. The stock was sold at an average price of $136.04, for a total transaction of $272,080.00. Following the sale, the director now owns 23,933 shares of the company's stock, valued at $3,255,845.32. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 1.70% of the stock is currently owned by corporate insiders.
在其他新聞方面，董事蒂莫西·M·林在8月1日(星期一)的一筆交易中出售了2,000股Quest診斷公司的股票。該股以136.04美元的平均價格出售，總成交金額為272,080.00美元。出售後，董事現在擁有23,933股該公司的股票，價值3,255,845.32美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的，該文件可通過這個環節。公司內部人士目前持有該公司1.70%的股份。
Institutional Investors Weigh In On Quest Diagnostics
機構投資者參與Quest Diagnostics
Hedge funds have recently made changes to their positions in the business. Northwestern Mutual Wealth Management Co. raised its holdings in shares of Quest Diagnostics by 5.8% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 11,867 shares of the medical research company's stock valued at $1,624,000 after buying an additional 654 shares during the last quarter. Meeder Asset Management Inc. bought a new stake in Quest Diagnostics during the first quarter worth approximately $524,000. NorthCrest Asset Manangement LLC raised its holdings in Quest Diagnostics by 515.2% during the second quarter. NorthCrest Asset Manangement LLC now owns 16,013 shares of the medical research company's stock worth $2,129,000 after purchasing an additional 13,410 shares in the last quarter. Argent Trust Co raised its holdings in Quest Diagnostics by 1.4% during the first quarter. Argent Trust Co now owns 27,237 shares of the medical research company's stock worth $3,728,000 after purchasing an additional 374 shares in the last quarter. Finally, Pinebridge Investments L.P. raised its holdings in Quest Diagnostics by 480.4% during the first quarter. Pinebridge Investments L.P. now owns 98,916 shares of the medical research company's stock worth $13,538,000 after purchasing an additional 81,873 shares in the last quarter. Institutional investors own 88.87% of the company's stock.
對衝基金最近對其在該業務中的頭寸進行了調整。西北互惠財富管理公司在第一季度增持了Quest Diagnostics的股票5.8%。西北互惠財富管理公司目前持有這家醫療研究公司11,867股股票，價值1,624,000美元，該公司在上個季度又購買了654股。Meeder資產管理公司在第一季度購買了Quest Diagnostics的新股份，價值約524,000美元。Northcrest Asset Manangement LLC在第二季度將其在Quest Diagnostics的持股增加了515.2%。Northcrest Asset Manangement LLC現在擁有這家醫療研究公司16,013股股票，價值2,129,000美元，上個季度又購買了13,410股。今年第一季度，銀色信託公司將其在Quest Diagnostics的持股增加了1.4%。Argent Trust Co目前持有27,237股這家醫療研究公司的股票，價值3,728,000美元，此前該公司在上個季度又購買了374股。最後，Pinebridge Investments L.P.在第一季度將其在Quest Diagnostics的持股增加了480.4%。PineBridge Investments L.P.在上個季度額外購買了81,873股後，現在擁有這家醫療研究公司98,916股股票，價值13,538,000美元。機構投資者持有該公司88.87%的股票。
About Quest Diagnostics
關於Quest診斷公司
(Get Rating)
(獲取評級)
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
Quest診斷公司在美國和國際上提供診斷測試、信息和服務。該公司開發和提供診斷信息服務，如常規測試、非常規和高級臨牀測試、解剖病理測試和其他診斷信息服務。
Featured Articles
專題文章
- Get a free copy of the StockNews.com research report on Quest Diagnostics (DGX)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Thor Industries Hammers Out A Bottom
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
- 免費獲取StockNews.com關於Quest Diagnostics(DGX)的研究報告
- 電動汽車電池製造商Freyr將在全球大舉擴張
- MarketBeat：回顧一週9/26-9/30
- 這是買入美光科技的難忘時刻
- 雷神工業走出谷底
- Keurig Dr Pepper與規模更大的競爭對手可口可樂(Coke&Pepsi)相比如何？
Receive News & Ratings for Quest Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quest Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
接收Quest診斷日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Quest Diagnostics和相關公司的最新新聞和分析師評級的每日簡明摘要。